EP Patent

EP0418716B1 — Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 1994-04-06 · 32y expired

What this patent protects

Patent listed against Tudorza Pressair.

Drugs covered by this patent

Tudorza Pressair (ACLIDINIUM BROMIDE) · Covis

Patent Metadata

Patent number: EP0418716B1
Jurisdiction: EP
Classification: —
Expires: 1994-04-06
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.